SQA Regulatory Surveillance Summary | 3Q/4Q 2025

Regulatory surveillance summary graphic for pharmaceutical compliance updates in Q3 and Q4 2025, highlighting global agencies including FDA, EMA, ANVISA, and WHO.

Staying informed on the latest pharmaceutical compliance updates is essential for navigating an increasingly complex global regulatory landscape. From evolving GMP requirements and regulatory guidance to enforcement actions and emerging risks, these updates directly impact how organizations manage quality, ensure compliance, and protect patient safety. This summary highlights key developments across major health authorities and […]

Regulatory Surveillance Summary | March 2020

By Laurel Hacche and Debra Cortner, SQA Associates Personal Care Products Council Personal Care Products Council (PCPC) COVID-19 Summary, 20 March 2020 In an effort to comply with health authorities’ recommendations for social distancing and in an abundance of caution, PCPC has closed their offices, and staff is working remotely to maintain business continuity and […]